Synthetic Receptors for Specific Cell Imaging and Signal Transduction
Open Access
- 1 October 2026
- journal article
- review article
- Published by MDPI AG in Applied Nano
- Vol. 7 (4) , 32
Abstract
Specific cell tracking or targeted modulation of cellular responses are often limited by the availability, specificity and effector functions of endogenous cell-surface receptors. Synthetic receptors with customizable functionality can overcome these limitations. Based on a qualitative survey of the literature, this narrative review describes the design, the functionality and the applications of nanobody-based synthetic receptor/ligand systems that employ either GFP/mCherry or the clinically approved humanized antibody Palivizumab as ligands. Depending on their molecular architecture, these systems can mediate cargo internalization for cell tracking or induce defined cellular responses through engineered interleukin, interferon, or Fas signaling pathways. We position these platforms within the broader field of synthetic receptors by discussing engineered GPCR- and Notch-based systems and briefly outline the development and clinical application of CAR T cells to illustrate the translational potential of synthetic receptor systems. Finally, we discuss the opportunities and limitations of GFP/mCherry- and Palivizumab-based systems, with particular emphasis on immunogenicity, in vivo applicability, manufacturability, scalability, and clinical translation. By linking modular receptor design to distinct functional outputs, this review highlights both the established value of GFP/mCherry- and Palivizumab-based synthetic receptor–ligand systems as experimental tools and their potential for future applications in molecular imaging and controlled signal transduction.Keywords
All Related Versions
Funding Information
- Heinrich-Heine-University (2023-13)
This publication has 106 references indexed in Scilit:
- Theranostic Toolbox for Neutrophil FunctionalizationAdvanced Science, 2025
- Synthetic receptors in medicine2022
- Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future ProspectsStem Cell Reviews and Reports, 2021
- An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancerAmerican Journal of Hematology, 2019
- Perfluorocarbon‐Based 19F MRI Nanoprobes for In Vivo Multicolor ImagingAngewandte Chemie International Edition, 2018
- Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking ExperimentsStem Cell Reviews and Reports, 2016
- Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half‐lives and sensitivityNMR in Biomedicine, 2013
- Perfluorocarbon Nanoemulsions for Quantitative Molecular Imaging and Targeted TherapeuticsAnnals of Biomedical Engineering, 2009
- Signaling mechanisms through cytokine receptors that share signal transducing receptor componentsCurrent Opinion in Immunology, 1995
- Expression of chimeric receptor composed of immunoglobulin-derived V resions and T-cell receptor-derived C regionsBiochemical and Biophysical Research Communications, 1987